Company Filing History:
2 out of 257 
2 out of 1,454 
1 out of 389 
Years Active: 2012-2017
Title: The Innovations of Pascal Barneoud
Introduction
Pascal Barneoud is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 3 patents to his name, Barneoud's work focuses on innovative therapeutic approaches.
Latest Patents
One of Barneoud's latest patents is for an H3 receptor antagonist aimed at treating Alzheimer's disease. This patent details methods of using a specific compound, 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide, in disease-modifying therapy for Alzheimer's and related tauopathies. Another significant patent involves a 6-pyrimidinyl-pyrimid-4-one derivative, which is utilized for the preventive and therapeutic treatment of diseases caused by abnormal activity of tau protein kinase 1, including Alzheimer's disease.
Career Highlights
Throughout his career, Barneoud has worked with prominent companies in the pharmaceutical industry. He has been associated with Mitsubishi Tanabe Pharma Corporation and Sanofi, where he has contributed to various research and development projects. His expertise in neuropharmacology has been instrumental in advancing therapeutic options for patients.
Collaborations
Barneoud has collaborated with esteemed colleagues, including Kenji Fukunaga and Kazutoshi Watanabe. These partnerships have fostered innovation and have been crucial in the development of his patented technologies.
Conclusion
Pascal Barneoud's contributions to the field of pharmaceuticals, particularly in neurodegenerative disease treatment, highlight his role as a leading inventor. His innovative patents and collaborations reflect his commitment to advancing medical science.